Peroxiredoxin 6 promotes lung cancer cell invasion by inducing urokinase-type plasminogen activator via p38 kinase, phosphoinositide 3-kinase, and Akt

Molecules and Cells

Volumn 28, Issue 6, 2009, Pages 583-588

  Lee, Seung Bum ^a   Ho, Jin Nyoung ^a   Yoon, Sung Hwan ^a   Kang, Ga Young ^a   Hwang, Sang Gu ^a   Um, Hong Duck ^a  

^a Korea Institute of Radiation and Medical Science   (South Korea)

Author keywords

Cancer; Cell signaling; Invasion; Peroxiredoxin 6

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE P38; PEROXIREDOXIN 6; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; UROKINASE;

ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; LUNG CANCER; PROTEIN FUNCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; CELL GROWTH PROCESSES; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; NEOPLASM INVASIVENESS; OXIDATIVE STRESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PEROXIREDOXIN VI; PROTO-ONCOGENE PROTEINS C-AKT; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSGENES; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

MAMMALIA;

EID: 76649112729     PISSN: 10168478     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10059-009-0152-6     Document Type: Article

References (39)

1. I.H. Bae M.J. Park S.H. Yoon S.W. Kang S.S. Lee K.M. Choi H.D. Um 2006 Bcl-w promotes gastric cancer cell invasion by inducing matrix metalloproteinase-2 expression via phospho-inositide 3-kinase, Akt and Sp1 Cancer Res 66 4991 4995 10.1158/0008-5472.CAN-05-4254 1:CAS:528: DC%2BD28XksF2jurY%3D 16707418 (Pubitemid 43844917)
2. C. Cabane A.S. Coldefy K. Yeow B. Derijard 2004 The p38 pathway regulates Akt both at the protein and transcriptional activation levels during myogenesis Cell. Signal. 16 1405 1415 10.1016/j.cellsig.2004.05.003 1:CAS:528: DC%2BD2cXnslenur8%3D 15381256 (Pubitemid 39277505)
3. A. Castagna P. Antonioli H. Astner M. Hamdan S.C. Rlghetti P. Perego F. Zunino P.G. Righetti 2004 A proteomic approach to cisplatin resistance in the cervix squamous cell carcinoma cell line A431 Proteomics 4 3246 3267 10.1002/pmic.200400835 1:CAS:528:DC%2BD2cXovVyntLo%3D 15378690 (Pubitemid 39372405)
4. X.Z. Chang D.Q. Li Y.F. Hou J. Wu J.S. Lu G.H. Di W. Jin Z.L. Ou Z.Z. Shen Z.M. Shao 2007 Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer Breast Cancer Res 9 R76 10.1186/bcr1789 17980029
5. W.C. Chen W.H. McBride K.S. Iwamoto C.L. Barber C.C. Wan Y.T. Oh Y.P. Liao J.H. Hong J. De Vellis H. Shau 2002 Induction of radioprotective peroxiredoxin-I by ionizing irradiation J. Neurosci. Res. 70 794 798 10.1002/jnr.10435 1:CAS:528:DC%2BD38XpsVOgsL0%3D 12444601 (Pubitemid 35416896)
6. Y.M. Chung Y.D. Yoo J.K. Park Y.T. Kim H.J. Kim 2001 Increased expression of peroxiredoxin confers resistance to cis-platin Anticancer Res 21 1129 1133 1:CAS:528:DC%2BD3MXksVOjt7k%3D 11396151
7. M.J. Duffy 2002 Urokinase-type plasminogen activator: a potent marker of metastatic potential in human cancers Biochem. Soc. Trans. 30 207 210 10.1042/BST0300207 1:CAS:528:DC%2BD38XjvVKhu7k%3D 12023852
8. M. Egeblad Z. Werb 2002 New functions for the matrix metalloproteinases in cancer progression Nat. Rev. Cancer 2 161 174 10.1038/nrc745 1:CAS:528:DC%2BD38Xis1KktL8%3D 11990853
9. C. Huang K. Jacobson M.D. Schaller 2004 MAP kinase and cell migration J. Cell Sci. 117 4619 4628 10.1242/jcs.01481 1:CAS:528:DC%2BD2cXptVygtb8%3D 15371522 (Pubitemid 39433429)
10. S. Immenschuh E. Baumgart-Vogt 2005 Peroxiredoxins, oxidative stress, and cell proliferation Anntioxid. Redox. Signal. 7 768 777 10.1089/ars.2005.7.768 1:CAS:528:DC%2BD2MXktVWit7w%3D (Pubitemid 40563217)
11. B.H. Jiang L.Z. Liu 2008 PI3K/PTEN signaling in tumorigenesis and angiogenesis Biochim. Biophys. Acta 1784 150 158 1:CAS:528: DC%2BD1cXptlertQ%3D%3D 17964232
12. P. Karihtala A. Mantyniemi S.W. Kang V.L. Kinnula Y. Soini 2003 Peroxiredoxins in breast carcinoma Clin. Cancer Res. 9 3418 3424 1:CAS:528:DC%2BD3sXotFCktrw%3D 12960131
13. D.K. Kim E.S. Cho J.K. Seong H.D. Um 2001 Adaptive concentrations of hydrogen peroxide suppress cell death by blocking the activation of SAPK/JNK pathway J. Cell Sci. 114 4329 4334 1:CAS:528:DC%2BD3MXptlKrtbo%3D 11739664
14. J.H. Kim P.N. Bogner N. Ramnath Y. Park J. Yu Y.M. Park 2007 Elevated peroxiredoxin 1, but not NF-E2-related factor 2, is an independent prognostic factor for disease recurrence and reduced survival in stage I non-small cell lung cancer Clin. Cacner Res. 13 3875 3882 10.1158/1078-0432.CCR-06-2893 1:CAS:528:DC%2BD2sXntFymtrs%3D (Pubitemid 47037594)
15. V.L. Kinnula S. Lehtonen R. Sormunen R. Kaarteenaho-Wiik S.W. Kang S.G. Rhee Y. Soini 2002 Overexpression of peroxiredoxins I, II, III, V, and VI in malignant mesothelioma J. Pathol. 196 316 323 10.1002/path.1042 1:CAS:528:DC%2BD38XisVWltLw%3D 11857495 (Pubitemid 34189421)
16. A. Kropotov V. Gogvadze O. Shupliakov N. Tomilin V.B. Serikov N.V. Tomilin B. Zhivotovsky 2006 Peroxiredoxin V is essential for protection against apoptosis in human lung carcinoma cells Exp. Cell Res. 312 2806 2815 10.1016/j.yexcr.2006.05.006 1:CAS:528:DC%2BD28XovVWqurw%3D 16781710 (Pubitemid 44246938)
17. J.B. Lee S.J. Yun H.Z. Chae Y.H. Won Y.P. Kim S.C. Lee 2002 Expression of peroxiredoxin and thioredoxin in dermatological disorders Br. J. Dermatol. 146 710 712 10.1046/j.1365-2133.2002.46845.x 11966715 (Pubitemid 34437796)
18. T.H. Lee S.U. Kim S.L. Yu S.H. Kim D.S. Park H.B. Moon S.H. Dho K.S. Kwon H.J. Kwon Y.H. Han, et al. 2003 Peroxiredoxin II is essential for sustaining life span of erythrocytes in mice Blood 101 5033 5038 10.1182/blood-2002-08-2548 1:CAS:528:DC%2BD3sXkslCjtr0%3D 12586629
19. S.B. Lee E.S. Cho H.S. Yang H. Kim H.D. Um 2005 Serum withdrawal kills U937 cells by inducing a positive mutual interaction between reactive oxygen species and phosphoinositide 3-kinase Cell. Signal. 17 197 204 10.1016/j.cellsig.2004.07.001 1:CAS:528:DC%2BD2cXos1eqsLo%3D 15494211 (Pubitemid 39371047)
20. S.B. Lee S.H. Hong H. Kim H.D. Um 2005 Co-induction of cell death and survival pathways by phosphoinositide 3-kinase Life Sci. 78 91 98 10.1016/j.lfs.2005.04.035 16154597 (Pubitemid 41527236)
21. S.T. Lehtonen A.M. Svensk Y. Soini P. Paakko P. Hirvikoski S.W. Kang M. Saily V.L. Kinnula 2004 Peroxiredoxins, a novel protein family in lung cancer Int. J. Cancer 111 514 521 10.1002/ijc.20294 1:CAS:528:DC%2BD2cXmsFeqtbo%3D 15239128 (Pubitemid 39045317)
22. D.Q. Li L. Wang F. Fei Y.F. Hou J.M. Luo Z. R. Wei-Chen J. Wu J.S. Lu G.H. Di Z.L. Ou, et al. 2006 Identification of breast cancer metastasis-associated proteins in an isogenic tumor metastasis model using two-dimensional gel electrophoresis and liquid chromatography-ion trap-mass spectrometry Pro-teomics 6 3352 3368 1:CAS:528:DC%2BD28Xmt1artL0%3D
23. C.A. Neumann D.S. Krause C.V. Carman S. Das D.P. Dubey J.L. Abraham R.T. Bronson Y. Fujiwara S.H. Orkin R.A. Van Etten 2003 Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defence and tumour suppression Nature 424 561 565 10.1038/nature01819 1:CAS:528:DC%2BD3sXlvVGis7g%3D 12891360 (Pubitemid 36975778)
24. L.S. Orlichenko D.C. Radisky 2008 Matrix metalloproteinases stimulate epithelial-mesenchymal transition during tumor development Clin. Exp. Metastasis 25 593 600 10.1007/s10585-008-9143-9 1:CAS:528:DC%2BD1cXhtVeis7fF 18286378
25. S.H. Park Y.M. Chung Y.S. Lee H.J. Kim J.S. Kim H.Z. Chae Y.D. Yoo 2000 Antisense of human peroxiredoxin II enhances radiation-induced cell death Clin. Cancer Res. 6 4915 4920 1:CAS:528:DC%2BD3MXotlersw%3D%3D 11156252
26. M.T. Park J.A. Choi M.J. Kim H.D. Um S. Bae C.M. Kang C.K. Cho S. Kang H.Y. Chung Y.S. Lee, et al. 2003 Suppression of extracellular signal-related kinase and activation of p38 MAPK are two critical events leading to caspase-8- and mitochondria-mediated cell death in phytosphingosine-treated human cancer cells J. Biol. Chem. 278 50624 50634 10.1074/jbc.M309011200 1:CAS:528: DC%2BD3sXpslSqurw%3D 14522966 (Pubitemid 37548910)
27. D. Park E. Shim Y. Kim Y.M. Kim H. Lee J. Choe D. Kang Y.S. Lee D. Jeoung 2008 C-FLIP promotes the motility of cancer cells by activating FAK and ERK, and increasing MMP-9 expression Mol. Cells 25 184 195 1:CAS:528: DC%2BD1cXlvFCjs7o%3D 18414015
28. M.J. Rane P.Y. Coxon D.W. Powell R. Webster J.B. Klein W. Pierce P. Ping K.R. McLeish 2001 p38 Kinasedependent MAPKAPK-2 activation functions as 3-phosphoinositide-dependent kinase-2 for Akt in human neutrophils J. Biol. Chem. 276 3517 3523 10.1074/jbc.M005953200 1:CAS:528:DC%2BD3MXhtFWisL4%3D 11042204
29. K.B. Reddy S.M. Nabha N. Atanaskova 2003 Role of MAP kinase in tumor progression and invasion Cancer Metastasis Rev 22 395 403 10.1023/A: 1023781114568 1:CAS:528:DC%2BD3sXjslyiu7o%3D 12884914 (Pubitemid 36791895)
30. S.G. Rhee S.W. Kang T.S. Chang W. Jeong K. Kim 2001 Peroxiredoxin, a novel family of peroxidases IUBMB Life 52 35 41 10.1080/15216540252774748 1:CAS:528:DC%2BD38Xmt12ktg%3D%3D 11795591
31. S.G. Rhee H.Z. Chae K. Kim 2005 Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling Free Radic. Biol. Med. 38 1543 1552 10.1016/j.freeradbiomed.2005.02.026 1:CAS:528:DC%2BD2MXks1WhurY%3D 15917183 (Pubitemid 40726061)
32. Y. Samuels K. Ericson 2006 Oncogenic PI3K and its role in cancer Curr. Opin. Oncol. 18 77 82 10.1097/01.cco.0000198021.99347.b9 1:CAS:528: DC%2BD2MXhtlahu73P 16357568 (Pubitemid 43740454)
33. L. Smith K.J. Welham M.B. Watson P.J. Drew M.J. Lind L. Cawkwell 2007 The proteomic analysis of cisplatin resistance in breast cancer cells Oncol. Res. 16 497 506 10.3727/096504007783438358 1:CAS:528:DC%2BD1cXitVKgtrY%3D 18306929 (Pubitemid 351211322)
34. X. Wang S.A. Phelan K. Forsman-Semb E.F. Taylor C. Petros A. Brown C.P. Lerner B. Paigen 2003 Mice with targeted mutation of peroxiredoxin 6 develop normally but are susceptible to oxidative stress J. Biol. Chem. 278 25179 25190 10.1074/jbc.M302706200 1:CAS:528:DC%2BD3sXltVSlt7s%3D 12732627 (Pubitemid 37548683)
35. Y. Wang S.I. Feinstein Y. Manevich Y.S. Ho A.B. Fisher 2006 Peroxiredoxin 6 gene-targeted mice show increased lung injury with paraquat-induced oxidative stress Antioxid. Redox. Signal. 8 229 237 10.1089/ars.2006.8.229 16487056 (Pubitemid 43324549)
36. 2-induced oxidative stress J. Cell. Biochem. 104 1274 1285 10.1002/jcb.21703 1:CAS:528:DC%2BD1cXosFykt74%3D 18260127 (Pubitemid 351961700)
37. Z.A. Wood E. Schroder J.R. Harri L.B. Poole 2003 Structure, mechanism and regulation of peroxiredoxins Trend Biochem. Sci. 28 32 40 10.1016/S0968- 0004(02)00003-8 1:CAS:528:DC%2BD3sXnvFGh 12517450 (Pubitemid 36051004)
38. T. Yanagawa T. Ishikawa T. Ishii K. Tabuchi S. Iwasa S. Bannai K. Omura H. Suzuki H. Yoshida 1999 Peroxiredoxin I expression in human thyroid tumors Cancer Lett. 145 127 132 10.1016/S0304-3835(99)00243-8 1:CAS:528: DyaK1MXlvVWlurc%3D 10530780 (Pubitemid 29459080)
39. Q.S. Zhang D.A. Maddock J.P. Chen S. Heo C. Chiu D. Lai K. Souza S. Mehta Y.S. Wan 2001 Cytokine-induced p38 activation feedback regulates the prolonged activation of Akt cell survival pathway initiated by reactive oxygen species in response to UV irradiation in human keratinocytes Int. J. Oncol. 19 1057 1061 1:CAS:528:DC%2BD3MXotlGit74%3D 11605009